Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Parkinson Disease: HELP
Articles from Italy
Based on 2,864 articles published since 2010
||||

These are the 2864 published articles about Parkinson Disease that originated from Italy during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline ESPEN guideline clinical nutrition in neurology. 2018

Burgos, Rosa / Bretón, Irene / Cereda, Emanuele / Desport, Jean Claude / Dziewas, Rainer / Genton, Laurence / Gomes, Filomena / Jésus, Pierre / Leischker, Andreas / Muscaritoli, Maurizio / Poulia, Kalliopi-Anna / Preiser, Jean Charles / Van der Marck, Marjolein / Wirth, Rainer / Singer, Pierre / Bischoff, Stephan C. ·Nutritional Support Unit, University Hospital Vall d'Hebron, Barcelona, Spain. Electronic address: rburgos@vhebron.net. · Nutrition Unit, University Hospital Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Fondazione Grigioni per il Morbo di Parkinson, Milano, Italy. · Nutrition Unit, ALS Centre, University Hospital of Limoges, Limoges, France. · Department of Neurology, University Hospital Münster, Germany. · Clinical Nutrition, Geneva University Hospitals, Geneva, Switzerland. · Cereneo (Center for Neurology and Rehabilitation) and University Department of Internal Medicine, Kantonsspital Aarau, Switzerland. · Department of Geriatrics, Alexianer Hospital Krefeld, Krefeld, Germany. · Department of Clinical Medicine, Sapienza, University of Rome, Rome, Italy. · Department of Nutrition, Laikon General Hospital, Athens, Greece. · Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium. · Department of Geriatric Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Geriatric Medicine, Marien Hospital Herne, Ruhr-University Bochum, Germany. · Department of General Intensive Care and Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Tel Aviv University, Petah Tikva, Israel. · Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany. ·Clin Nutr · Pubmed #29274834.

ABSTRACT: Neurological diseases are frequently associated with swallowing disorders and malnutrition. Moreover, patients with neurological diseases are at increased risk of micronutrient deficiency and dehydration. On the other hand, nutritional factors may be involved in the pathogenesis of neurological diseases. Multiple causes for the development of malnutrition in patients with neurological diseases are known including oropharyngeal dysphagia, impaired consciousness, perception deficits, cognitive dysfunction, and increased needs. The present evidence- and consensus-based guideline addresses clinical questions on best medical nutrition therapy in patients with neurological diseases. Among them, management of oropharyngeal dysphagia plays a pivotal role. The guideline has been written by a multidisciplinary team and offers 88 recommendations for use in clinical practice for amyotrophic lateral sclerosis, Parkinson's disease, stroke and multiple sclerosis.

2 Guideline Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. 2015

Odin, P / Ray Chaudhuri, K / Slevin, J T / Volkmann, J / Dietrichs, E / Martinez-Martin, P / Krauss, J K / Henriksen, T / Katzenschlager, R / Antonini, A / Rascol, O / Poewe, W / Anonymous2260838. ·Department of Neurology, Lund University Hospital, 221 85 Lund, Sweden; Klinikum-Bremerhaven, D-27574 Bremerhaven, Germany. Electronic address: per.odin@med.lu.se. · King's College London, and National Parkinson Foundation Centre of Excellence, Dept of Neurology, King's College Hospital, London, UK. · Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L-445, 740 South Limestone Street, Lexington, KY 40536-0284, USA. · Department of Neurology, University Hospital of Würzburg, 97080 Würzburg, Germany. · Department of Neurology, Oslo University Hospital and University of Oslo, N-0424 Oslo, Norway. · National Center for Epidemiology and CIBERNED, ISCIII, Avenida Monforte de Lemos 5, 28029 Madrid, Spain. · Department of Neurosurgery, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. · University Hospital of Bispebjerg, Bispebjerg Bakke 23, 2400 København, NV, Denmark. · Department of Neurology and Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Sozialmedizinisches Zentrum Ost - Donauspital, 1220 Wien Langobardenstraße 122, Austria. · Parkinson and Movement Disorders Unit, IRCCS Hospital San Camillo, Venice, Italy. · Clinical Investigation Center 1436 and Department of Clinical Pharmacology, INSERM and University Hospital of Toulouse, Toulouse University, 37 alées Jules Giesde, 31000 Toulouse, France; Clinical Investigation Center 1436 and Department of Neurosciences, INSERM and University Hospital of Toulouse, Toulouse University, 37 alées Jules Giesde, 31000 Toulouse, France. · Innsbruck Medical University/University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria. ·Parkinsonism Relat Disord · Pubmed #26233582.

ABSTRACT: Navigate PD was an educational program established to supplement existing guidelines and provide recommendations on the management of Parkinson's disease (PD) refractory to oral/transdermal therapies. It involved 103 experts from 13 countries overseen by an International Steering Committee (ISC) of 13 movement disorder specialists. The ISC identified 71 clinical questions important for device-aided management of PD. Fifty-six experts responded to a web-based survey, rating 15 questions as 'critically important;' these were refined to 10 questions by the ISC to be addressed through available evidence and expert opinion. Draft guidance was presented at international/national meetings and revised based on feedback. Key take-home points are: • Patients requiring levodopa >5 times daily who have severe, troublesome 'off' periods (>1-2 h/day) despite optimal oral/transdermal levodopa or non-levodopa-based therapies should be referred for specialist assessment even if disease duration is <4 years. • Cognitive decline related to non-motor fluctuations is an indication for device-aided therapies. If cognitive impairment is mild, use deep brain stimulation (DBS) with caution. For patients who have cognitive impairment or dementia, intrajejunal levodopa infusion is considered as both therapeutic and palliative in some countries. Falls are linked to cognitive decline and are likely to become more frequent with device-aided therapies. • Insufficient control of motor complications (or drug-resistant tremor in the case of DBS) are indications for device-aided therapies. Levodopa-carbidopa intestinal gel infusions or subcutaneous apomorphine pump may be considered for patients aged >70 years who have mild or moderate cognitive impairment, severe depression or other contraindications to DBS.

3 Guideline EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. 2012

Sorbi, S / Hort, J / Erkinjuntti, T / Fladby, T / Gainotti, G / Gurvit, H / Nacmias, B / Pasquier, F / Popescu, B O / Rektorova, I / Religa, D / Rusina, R / Rossor, M / Schmidt, R / Stefanova, E / Warren, J D / Scheltens, P / Anonymous1620734. ·Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy. sorbi@unifi.it ·Eur J Neurol · Pubmed #22891773.

ABSTRACT: BACKGROUND AND OBJECTIVES: The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were published. The current guidelines involve the revision of the dementia syndromes outside of AD, notably vascular cognitive impairment, frontotemporal lobar degeneration, dementia with Lewy bodies, corticobasal syndrome, progressive supranuclear palsy, Parkinson's disease dementia, Huntington's disease, prion diseases, normal-pressure hydrocephalus, limbic encephalitis and other toxic and metabolic disorders. The aim is to present a peer-reviewed evidence-based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists and other specialist physicians responsible for the care of patients with dementing disorders. It represents a statement of minimum desirable standards for practice guidance. METHODS: The task force working group reviewed evidence from original research articles, meta-analyses and systematic reviews, published by June 2011. The evidence was classified (I, II, III, IV) and consensus recommendations graded (A, B, or C) according to the EFNS guidance. Where there was a lack of evidence, but clear consensus, good practice points were provided. RESULTS AND CONCLUSIONS: New recommendations and good practice points are made for clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of behavioural and psychological symptoms in dementia, legal issues, counselling and support for caregivers. All recommendations were revised as compared with the previous EFNS guidelines. The specialist neurologist together with primary care physicians play an important role in the assessment, interpretation and treatment of symptoms, disability and needs of dementia patients.

4 Editorial Editorial: New Advances in Neurorehabilitation. 2019

Tamburin, Stefano / Smania, Nicola / Saltuari, Leopold / Hoemberg, Volker / Sandrini, Giorgio. ·Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. · Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Verona, Italy. · Research Unit for Neurorehabilitation South Tyrol, Bolzano, Italy. · Department of Neurology, State Hospital Hochzirl, Zirl, Austria. · Department of Neurology, Stiftung Rehabilitation Heidelberg Gesundheitszentrum Bad Wimpfen GmbH, Bad Wimpfen, Germany. · Neurorehabilitation Unit, Istituto di Ricovero e Cura a Carattere Scientifico C. Mondino Foundation, Pavia, Italy. · Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. ·Front Neurol · Pubmed #31681155.

ABSTRACT: -- No abstract --

5 Editorial Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease. 2019

Rodríguez-Violante, Mayela / Antonini, Angelo. ·Movement Disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico. · Department of Neurosciences, University of Padova, Padua, Italy. ·Front Neurol · Pubmed #31572290.

ABSTRACT: -- No abstract --

6 Editorial An association between bipolar disorder and Parkinson disease: When mood makes you move. 2019

Pontone, Gregory M / Koch, Giacomo. ·From the Department of Psychiatry and Behavioral Sciences (G.M.P.) and Department of Neurology (G.M.P.), Johns Hopkins University School of Medicine, Baltimore, MD · Stroke Unit (G.K.), Department of Neuroscience, Tor Vergata University Hospital · and Non Invasive Brain Stimulation Lab (G.K.), Santa Lucia Foundation IRCCS, Rome, Italy. ·Neurology · Pubmed #31118246.

ABSTRACT: -- No abstract --

7 Editorial Parkinson's disease, dopamine, and eating and weight disorders: an illness in the disease? 2019

Melchionda, Nazario / Cuzzolaro, Massimo. ·Formerly Alma Mater University, Bologna, Italy. · Formerly Sapienza University, Roma, Italy. massimo.cuzzolaro@gmail.com. ·Eat Weight Disord · Pubmed #30949962.

ABSTRACT: -- No abstract --

8 Editorial A nurse-led model increases quality of care in Parkinson disease. 2019

Calabresi, Paolo / Nigro, Pasquale / Schwarz, Heidi Beck. ·From the Section of Neurology (P.C., P.N.), Department of Medicine, University of Perugia, Italy · and Department of Neurology (H.B.S.), University of Rochester, NY. ·Neurology · Pubmed #30902906.

ABSTRACT: -- No abstract --

9 Editorial PPN-DBS: A utopic vision or a realistic perspective? 2019

Stefani, Alessandro / Galati, Salvatore. ·Parkinson Center, University of Rome Tor Vergata, Italy. · Neurocentro della Svizzere Italiana, Lugano, Switzerland. ·Neurobiol Dis · Pubmed #30885790.

ABSTRACT: -- No abstract --

10 Editorial Brainstem avenues in Parkinson's disease research. 2019

Bologna, Matteo / Berardelli, Alfredo. ·Department of Human Neurosciences, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli, IS, Italy. ·Clin Neurophysiol · Pubmed #30765197.

ABSTRACT: -- No abstract --

11 Editorial The sweet road to Parkinson's disease. 2019

Renaud, Justine / Simola, Nicola / Martinoli, Maria-Grazia. ·Cellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, Canada. · Department of Biomedical Sciences, Università di Cagliari, Cagliari, Italy. · National Institute of Neuroscience, Università di Cagliari, Cagliari, Italy. · Department of Psychiatry and Neuroscience, Université Laval and CHU Research Center, Québec, Canada. ·Aging (Albany NY) · Pubmed #30708352.

ABSTRACT: -- No abstract --

12 Editorial The democratic aspect of machine learning: Limitations and opportunities for Parkinson's disease. 2019

Bonanni, Laura. ·Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy. ·Mov Disord · Pubmed #30597623.

ABSTRACT: -- No abstract --

13 Editorial The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss. 2018

Adams, Jamie L / La Morgia, Chiara. ·From the Department of Neurology (J.L.A.) and Center for Health + Technology (J.L.A.), University of Rochester Medical Center, NY · IRCCS Institute of Neurological Sciences of Bologna (C.L.M.), Neurology Unit, Bellaria Hospital · and Department of Biomedical and Neuromotor Sciences (C.L.M.), University of Bologna, Italy. ·Neurology · Pubmed #30111551.

ABSTRACT: -- No abstract --

14 Editorial GABA and hallucinations in Parkinson disease: Who is that sitting on my chair? 2018

Onofrj, Marco / Gilbert, Gordon J. ·From Clinica Neurologica (M.O.), Department of Neurosciences, Imaging and Clinical Sciences, Università Chieti-Pescara, Chieti, Italy · and Department of Physiology and Biophysics (G.J.G.), University of South Florida, Tampa. ·Neurology · Pubmed #30021918.

ABSTRACT: -- No abstract --

15 Editorial Dyskinesia in Parkinson's disease: a clinical complication and an open scientific question. 2018

Carta, Manolo / Hirsch, Etienne. ·Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria SP 8, 09042, Monserrato, Italy. manolocarta@unica.it. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, 75013, Paris, France. ·J Neural Transm (Vienna) · Pubmed #30014356.

ABSTRACT: -- No abstract --

16 Editorial Editorial: New Advanced Wireless Technologies for Objective Monitoring of Motor Symptoms in Parkinson's Disease. 2018

Irrera, Fernanda / Cabestany, Joan / Suppa, Antonio. ·Department of Information Engineering, Electronics and Telecommunication, Sapienza University of Rome, Rome, Italy. · Technical Research Centre for Dependency Care and Autonomous Living (CETpD), Universitat Politècnica de Catalunya, Vilanova i la Geltrú, Spain. · Sense4Care, Cornellà de Llobregat, Spain. · Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy. · Istituto Neurologico Mediterraneo (IRCCS), Pozzilli, Italy. ·Front Neurol · Pubmed #29670574.

ABSTRACT: -- No abstract --

17 Editorial Deep brain stimulation and motor synergies in Parkinson's disease. 2018

Palermo, E / Suppa, A. ·Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Italy. · Department of Human Neuroscience, Sapienza University of Rome, Italy; IRCCS Neuromed Institute, Pozzilli IS, Italy. Electronic address: antonio.suppa@uniroma1.it. ·Clin Neurophysiol · Pubmed #29661596.

ABSTRACT: -- No abstract --

18 Editorial The need for an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson's disease. 2018

Daniele, A / Lacidogna, G. ·Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy. ·Eur J Neurol · Pubmed #29509993.

ABSTRACT: -- No abstract --

19 Editorial News on the journal Neurological Sciences in 2017. 2018

Di Donato, Ilaria / Federico, Antonio. ·Department of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Viale Bracci 2, 53100, Siena, Italy. · Department of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Viale Bracci 2, 53100, Siena, Italy. federico@unisi.it. ·Neurol Sci · Pubmed #29327225.

ABSTRACT: -- No abstract --

20 Editorial Can a cognitive rehabilitation program in early stages of Parkinson's disease improve cognition, apathy and brain functional connectivity for up to 18 months? 2018

Daniele, A / Panza, F. ·Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy. · Geriatric Unit and Gerontology-Geriatrics Research Laboratory, Department of Medical Sciences, IRCCS 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy. · Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience and Sense Organs, University of Bari 'Aldo Moro', Bari, Italy. · Neurodegenerative Disease Unit, Department of Clinical Research in Neurology, University of Bari 'Aldo Moro', Azienda Ospedaliera 'Card. G. Panico', Tricase, Italy. ·Eur J Neurol · Pubmed #29215769.

ABSTRACT: -- No abstract --

21 Editorial Classifying tremor: Language matters. 2018

Albanese, Alberto. ·Department of Neurology, Humanitas Research Hospital, Rozzano, Milano, Italy. · Department of Neurology, Catholic University, Milano, Italy. ·Mov Disord · Pubmed #29193400.

ABSTRACT: -- No abstract --

22 Editorial In vivo evaluation of central cholinergic circuits in Parkinson's disease using transcranial magnetic stimulation. 2017

Nardone, Raffaele / Trinka, Eugen. ·Department of Neurology, Franz Tappeiner Hospital, Merano, Italy; Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria. Electronic address: raffaele.nardone@asbmeran-o.it. · Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria; Centre for Cognitive Neurosciences Salzburg, Salzburg, Austria; University for Medical Informatics and Health Technology, UMIT, Hall in Tirol, Austria. ·Clin Neurophysiol · Pubmed #28427894.

ABSTRACT: -- No abstract --

23 Editorial A neurorestorative approach to Parkinson's disease. 2017

Diana, Giovanni / Ciotti, Maria Teresa / Musilli, Marco. ·Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Roma, Italy. ·Oncotarget · Pubmed #28423348.

ABSTRACT: -- No abstract --

24 Editorial Parkinson's disease: no NOP, new hope. 2017

Arcuri, Ludovico / Mercatelli, Daniela / Morari, Michele. ·Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy. ·Oncotarget · Pubmed #28086211.

ABSTRACT: -- No abstract --

25 Editorial Nonmotor symptoms in Parkinson's disease: are we still waiting for the honeymoon? 2016

Colosimo, C / Bhidayasiri, R. ·Department of Neurology, Santa Maria University Hospital, Terni, Italy. carlo.colosimo@uniroma1.it. · Department of Medicine, Faculty of Medicine, Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. · Department of Rehabilitation Medicine, Juntendo University, Tokyo, Japan. ·Eur J Neurol · Pubmed #27611181.

ABSTRACT: -- No abstract --

Next